Guardant Health
GH
#3785
Rank
$2.51 B
Marketcap
$20.63
Share price
14.87%
Change (1 day)
-10.23%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2023 (TTM): -$0.48 B

According to Guardant Health 's latest financial reports the company's current earnings (TTM) are -$0.48 B. In 2022 the company made an earning of -$0.66 B a decrease over its 2021 earnings that were of -$0.39 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2023

Annual earnings

Year Earnings Change
2023 (TTM)-$0.48 B-26.73%
2022-$0.66 B69.96%
2021-$0.39 B56.35%
2020-$0.25 B252.69%
2019-$69.73 M-17.22%
2018-$84.23 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$3.3 M-100.69%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.44 B-9.24%๐Ÿ‡บ๐Ÿ‡ธ USA